What stage does Claris Ventures invest at?

Claris Ventures invests at the Pre-Seed, Seed, Series A stages.

What sectors does Claris Ventures focus on?

Claris Ventures focuses on Biotech, Healthtech, Medical Devices.

Where is Claris Ventures located?

Claris Ventures is headquartered in Turin, IT.

Does Claris Ventures lead rounds?

Claris Ventures typically participates in rounds rather than leading them.

Claris Ventures

Venture capital

Turin · Pre-Seed–Series A · 14 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Claris Ventures backs early-stage biopharma companies that combine a clear vision with solid scientific evidence. The firm targets innovators addressing significant unmet clinical needs across areas including rare diseases, oncology and immunology, as well as other life-threatening disease areas. Beyond capital, Claris provides scientific competence and hands-on support to help jump-start clinical development programs, aiming to create value driven by clinical evidence. Its fund, Claris Biotech I, is backed by European institutional programs including InnovFin Equity under Horizon 2020, the European Fund for Strategic Investments, AlpGIP, and the Pan-European Guarantee Fund.

Invests inBiotech Healthtech Medical DevicesEuropeItalyTurin

Source: firm website, verified Aug 3, 2026.

Stage

Pre-Seed–Series A

Turin, IT

Leads rounds

Follows

Instruments

Equity

Founded

2019

AUM

$92M

Tracked investments

Team · 14 people

from the firm's website & public directories

Pietro Puglisi· Managing Partner· Italyin 𝕏

Pietro Puglisi is Co-Founder and Managing Partner at Claris Ventures. Trained as a biomedical engineer with an MBA from the Collège des Ingénieurs, he has a background in life sciences management consulting and venture investing. He sits on the boards of several biotech companies and focuses on the connection between science and patient impact.

p•••@clarisventures.comreveal

Giulia Vestri· Partner· Turin, Piedmont, Italyin

Partner at Claris Ventures with a PhD in Immunology and an Executive MBA, bringing experience in business development and strategy across pharma and biotech.

Ciro Spedaliere· Partner· Piedmontin 𝕏

Co-founder and Managing Partner at Claris Ventures with a background in venture capital, product management and strategic planning. Collaborates with universities on technology transfer and teaches venture capital.

c•••@clarisventures.comreveal

Araceli Albano· Internal Accounting & Administration· Greater Turin Metropolitan Areain

Supports internal accounting and administration at Claris Ventures, with experience in general accounting, administrative operations and payroll.

Cristina Tumiatti· Independent Director· Collegno, Piedmont, Italyin

Independent Director and entrepreneur with experience in international business development and governance roles within the Italian innovation ecosystem.

Gianmarco Pallavicini· Senior Associate· Greater Turin Metropolitan Areain

Senior Associate at Claris Ventures with a background in molecular biotechnology and neuroscience; supports early-stage biotech investments via scientific assessment and due diligence.

Laura Iris Ferro· Senior Advisor· Milan, Lombardy, Italyin

Senior Advisor and healthcare executive with MD and MBA training and leadership experience across pharma and biotech, including founding and scaling ventures.

Luca Melindo· Senior Advisor· Turin, Piedmont, Italyin

Senior Advisor and financial executive with experience originating and managing private equity transactions, including development capital, buyouts and listings.

Manilo Marocco· Senior Advisor

Senior Advisor and finance professional with three decades across investment banking, private equity, fund management and seed/impact investing.

Michael Hodges· Entrepreneur in Residence· San Diego, California, United Statesin

Entrepreneur in Residence and pharmaceutical physician with expertise in RNA therapeutics, infectious diseases and clinical development; supports scientific evaluation and portfolio strategy.

Raffaele Troya· Finance & Administration Manager· Turin, Piedmont, Italyin

Oversees finance and administration at Claris Ventures, with prior experience in audit, post-deal accounting and financial analysis.

Roberto De Ponti· Senior Advisor· Monte-Carlo, Monaco, Monacoin

Senior Advisor and pharmacist / EU Qualified Person with deep experience in pharmaceutical development, corporate ventures and strategic investments in oncology and rare diseases.

Giuditta Magnifico· Associate· Turin, Piedmont, Italyin

Associate at Claris Ventures; a biomedical engineer supporting sourcing and assessment of early-stage biotech opportunities and due diligence.

g•••@clarisventures.comreveal

Paolo Vigo· Investment Manager· Italyin

Investment Manager at Claris Ventures; a mechanical engineer with an MBA who works at the intersection of data analysis and early-stage biotech, with prior operational and research roles.

p•••@clarisventures.comreveal

What they invest in

from 7 of 11 portfolio companies

Biotech ×7Healthtech ×4Deep Tech ×2Medical Devices ×2AI & Machine Learning ×1Digital Health ×1

HQs:Italy×1

Investments · 11 tracked

founders shown can be your intro path

Alkemist Bioalkemistbio.comin

ALKemist Bio develops immunotherapies targeting ALK-positive cancers, using chimeric antigen receptor (CAR) T cells and T cell receptor (TCR) engineered T cells to eliminate treatment-resistant tumors.

BiotechDigital HealthMedical Devices

Arbitro per le Controversie Finanziarieconsob.it

Haptenahaptena.comin

Haptena Therapeutics is a biotech company developing next-generation immunotherapies for oncogene-driven, genetically defined cancers, starting with KRAS-driven tumors.

BiotechHealthtech

Chiara Ambrogio(Co-founder)Roberto Chiarle(Co-founder)

Heqettherapeuticsheqettherapeutics.comin

Heqet Therapeutics is a pre-clinical stage biotech developing non-coding RNA-based therapies for cardiovascular diseases, with a focus on acute myocardial infarction.

BiotechMedical Devices

Mauro Giacca(Founder (Professor of Cardiovascular Sciences))

IAMA Therapeuticsiamatherapeutics.com

Kither Biotechkitherbiotech.com

Lever Bioleverbio.comin

Lever Bio is an immuno-oncology company developing compounds that reprogram the solid tumor microenvironment to enhance the recruitment, activation, and function of cytotoxic T lymphocytes against solid tumors.

BiotechDeep TechHealthtech

NeoPhore Limitedneophore.com

Page Therapeuticspagetherapeutics.comin

PAGE Therapeutics is an oncology drug development company developing compounds that disrupt cell-cell adhesion to dissolve circulating tumor cell (CTC) clusters and block cancer metastasis.

BiotechHealthtech

Daniele Scarinci(CEO & Executive Director)Nicola Aceto(Co-founder & Chief Science Officer)Christoph Rochlitz(Co-founder & Chief Medical Officer)Katharina Venturi(Chief Operating Officer)

Resalis Therapeuticsresalistherapeutics.comin

Resalis Therapeutics develops RNA-based therapies targeting non-coding RNAs to address the underlying causes of complex metabolic disorders.

BiotechHealthtech

Sibyllasibyllabiotech.itin 𝕏

Sibylla Biotech develops PPI-FIT, a drug discovery technology that uses quantum physics and mathematical modeling to characterize protein folding pathways at atomic resolution.

AI & Machine LearningBiotechDeep TechTrento, IT

Emiliano Biasini(Co-founder)Pietro Faccioli(Co-founder)Giovanni Spagnolli(Co-founder, CTO)Maria Letizia Barreca(Co-founder)Graziano Lolli(Co-founder)

Frequently asked questions

What stage does Claris Ventures invest at?: Claris Ventures invests at the Pre-Seed, Seed, Series A stages.
What sectors does Claris Ventures focus on?: Claris Ventures focuses on Biotech, Healthtech, Medical Devices.
Where is Claris Ventures located?: Claris Ventures is headquartered in Turin, IT.
Does Claris Ventures lead rounds?: Claris Ventures typically participates in rounds rather than leading them.

Media · Podcasts & interviews

featuring the team

Pietro Puglisi (Claris Ventures): Sostenere la crescita e dare visione con investimenti nel settore

Sanità33 · Pietro Puglisi

Images

Co-investors · 3

CDP Venture Capital

CDP Venture Capital SGR is an Italian venture capital fund manager that invests in strategic sectors for Italy's economic growth through direct and indirect funds. It is Italy's leading VC fund manager and among the largest in Europe.

Both backed · 3

SibyllaIAMA TherapeuticsKither Biotech

3B Future Health Fund

3B Future Health Fund invests in early-stage private healthcare and biotech companies in the US, Europe and Israel that address high unmet patient needs, with a focus on oncology and rare diseases.

Both backed · 3

SibyllaKither BiotechNeoPhore Limited

$12M

Seroba Life Sciences

Seroba is a Dublin-based life sciences venture capital firm investing in early-stage biotech and medtech companies developing new therapeutics and medical devices.

Both backed · 1

Sibylla

$540K – $7.6M

Firms observed investing alongside Claris Ventures, from public investor directories. Shared companies are the overlap with Claris Ventures's recorded portfolio.

Similar investors

Draper Associates

Draper Associates is a venture capital firm that invests in technology startups across AI, robotics, blockchain, healthcare, aerospace, and frontier deep-tech fields.

$500K – $5M

Foresite Capital

Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, backing companies across all stages of growth. It applies a data science-driven approach to invest in businesses leveraging biology and big data to transform healthcare.

Forbion

Forbion is a global venture capital firm focused on advancing biotech innovations and sustainable solutions aimed at improving human and planetary health.

Pontifax Venture Capital

Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.